Clinicians Around the Globe Continue to Adapt NCCN Guidelines for Regional Cancer Treatment
Chinese oncologists and administrators visit the National Comprehensive Cancer Network® (NCCN®) and Memorial Sloan-Kettering Cancer Center. Clinicians around the globe recognize the value of NCCN’s evidence-based Guidelines with a number of recent international collaborations and regional adaptations.
FORT WASHINGTON, PA — The National Comprehensive Cancer Network (NCCN) welcomed experts in hematology oncology from China to the United States as part of the NCCN Global Leadership Exchange Program. The Chinese delegation of oncologists and administrators visited NCCN and Memorial Sloan-Kettering Cancer Center on December 8 and 9 to gain insight about the latest clinical research and treatment for cancer as well as the application of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines™).
The NCCN Global Leadership Exchange Program demonstrates the escalating presence of NCCN in Asia, and is but one example of NCCN’s influence globally.
This past fall, Robert Swarm, MD, of Washington University School of Medicine and Chair of the NCCN Guidelines™ for Adult Cancer Pain, visited China to educate local oncology professionals on the fundamentals of the NCCN Guidelines and the data that supports some of the key decisions behind featured recommendations. He stressed the importance of considering symptom control to be a core component of comprehensive cancer care; to emphasize the need, Dr. Swarm noted how, in developed countries, one in eight people are at risk of dying of cancer with severe pain.
China has had a long-standing collaboration with NCCN in the development of the Chinese Editions of the NCCN Guidelines - the most authoritative reference for oncology practice in China. This collaboration continues to thrive with the development of a region-specific, Chinese language version of the NCCN Guidelines for Adult Pain. The NCCN Guidelines for Adult Pain: China Edition will be available on the international portion of NCCN.org in early 2011.
NCCN regularly collaborates with international organizations to create and distribute translationed versions of the NCCN Guidelines, which may include modifications representative of metabolic differences in populations, technological considerations, and regulatory status of agents used in cancer management, such as availabilities of drugs, biologics, devices, and procedures. For additional information on NCCN International Programs, visit NCCN.org/international.
The National Comprehensive Cancer Network® (NCCN®), a not-for-profit alliance of 23 of the world's leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer. Through the leadership and expertise of clinical professionals at NCCN Member Institutions, NCCN develops resources that present valuable information to the numerous stakeholders in the health care delivery system. As the arbiter of high-quality cancer care, NCCN promotes the importance of continuous quality improvement and recognizes the significance of creating clinical practice guidelines appropriate for use by patients, clinicians, and other health care decision-makers. The primary goal of all NCCN initiatives is to improve the quality, effectiveness, and efficiency of oncology practice so patients can live better lives. For more information, visit NCCN.org.